Clinical trial
Pregabalin for Abdominal Pain From Adhesions
NCT00310765 · Henry Ford Health System, Other · Terminated
Key facts
| NCT number | NCT00310765 |
|---|---|
| Title | Pregabalin for Abdominal Pain From Adhesions |
| Official title | Pregabalin for the Treatment of Abdominal Pain From Adhesions: Placebo Controlled Trial |
| Lead sponsor | Henry Ford Health System, Other |
| Collaborators | Pfizer Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Abdominal Pain, Surgical Adhesions |
| Intervention type | Drug |
| Interventions | Pregabalin 75 or 150 mg BID for 7 weeks followed by open label pregabalin 150 mg BID for 4 weeks, Placebo first followed by open label pregabalin |
| Enrollment | 18 |
| Start date | Mar 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Apr 4, 2006 |
| Last update posted | Oct 23, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: